Search Within

Hikmat Al-Ahmadie

  1. "2019"
Formats
  1. Meeting Abstract (35)
  2. Journal Article (16)
  3. Correspondence (1)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (54)
  2. Human Oncology and Pathogenesis Program (28)
  3. GSK Faculty (27)
  4. Department of Medicine (25)
  5. Genitourinary Oncology Service (25)
  6. Solid Tumor Oncology Division (25)

More Groups

People
  1. Victor Reuter (37)
  2. Anuradha Gopalan (33)
  3. Samson Fine (33)
  4. Sahussapont Sirintrapun (31)
  5. Yingbei Chen (31)
  6. David Solit (18)

More People

Years
  1. 2019 (54)
Publications
  1. Modern Pathology (16)
  2. Laboratory Investigation (13)
  3. Journal of Clinical Oncology (7)
  4. American Journal of Surgical Pathology (4)
  5. Cancer Research (2)
  6. European Urology Focus (2)

More Publications

Publishers
  1. Nature Research (16)
  2. Nature Publishing Group (15)
  3. American Society of Clinical Oncology (7)
  4. Lippincott Williams & Wilkins (4)
  5. American Association for Cancer Research (3)
  6. Elsevier Science, Inc. (3)

More Publishers

Results (54)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • "Primary" and "secondary" muscle-invasive bladder cancer is more than just a surrogate for molecular subtypes
    Correspondence

    Pietzak, E. J.; Al-Ahmadie, H.; Walasek, A.; Bajorin, D. F.; Rosenberg, J. E.; Bochner, B. H.; Solit, D. B.; Iyer, G.
    Translational Cancer Research (2019)

    Fulltext@MSK | Save
  • Repression of transcription factor AP-2 alpha by PPARĪ³ reveals a novel transcriptional circuit in basal-squamous bladder cancer
    Journal Article

    Yamashita, H.; Kawasawa, Y. I.; Shuman, L.; Zheng, Z.; Tran, T.; Walter, V.; Warrick, J. I.; Chen, G.; Al-Ahmadie, H.; Kaag, M.; more...
    Oncogenesis (2019)

    Fulltext@MSK | Save
  • A phase III, randomized, open label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine plus cisplatin (G plus C) for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (MIBC) (NIAGARA)
    Meeting Abstract

    Powles, T.; Meeks, J. J.; Galsky, M. D.; Van der Heijden, M. S.; Nishiyama, H.; Al-Ahmadie, H.; Gupta, A. K.; Ye, J.; Donegan, S. E.; Ghiorghiu, D. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC)
    Meeting Abstract

    Funt, S. A.; Jatwani, K.; Makris, M.; Regazzi, A. M.; Lee, C. H.; Teo, M. Y.; McHugh, D. J.; McCoy, A. S.; Hettich, G.; Wong, P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical features and outcomes of secondary somatic malignancy (SSM) arising from teratoma in late relapse germ cell tumor (GCT)
    Meeting Abstract

    Wong, N. C.; Dason, S.; Dean, L. W.; Isharwal, S.; Donoghue, M.; Jia, L.; Joseph, G.; Tap, W. D.; Funt, S. A.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Molecular stratification of high-grade unclassified renal cell carcinoma to improve prognostication and management strategy
    Meeting Abstract

    Chen, Y.; Di Natale, R. G.; Jayakumaran, G.; Ghanaat, M.; Marcon, J.; Brannon, A. R.; Al-Ahmadie, H.; Fine, S.; Gopalan, A.; Sirintrapun, S. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical features and outcomes of secondary somatic malignancy (SSM) associated with primary mediastinal nonseminomatous germ cell tumors (PM-NSGCT)
    Meeting Abstract

    Dean, L. W.; Wong, N. C.; Dason, S.; Isharwal, S.; Donoghue, M.; Jia, L.; Tap, W. D.; Joseph, G.; Funt, S. A.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Muscle invasive bladder cancer (MIBC) demonstrates neoadjuvant cisplatin-based chemotherapy (NAC) related changes in molecular subtype and immune infiltration
    Meeting Abstract

    Funt, S. A.; Solovyov, A.; Faltas, B. M.; Iyer, G.; Boyd, M. E.; Cipolla, C. K.; Regazzi, A. M.; Teo, M. Y.; Lee, C. H.; Al-Ahmadie, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma
    Meeting Abstract

    Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical validation of a genomics-based classifier to predict tissue of origin from targeted tumor sequencing
    Meeting Abstract

    Zheng, Y.; Penson, A. V.; Camacho, N.; Biederstedt, E.; Zehir, A.; Kandoth, C.; Syed, A.; Varghese, A. M.; Al-Ahmadie, H. A.; Schultz, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save